Related Experiment Video
Updated: Apr 17, 2026
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
Risk profile of breast cancer following atypical hyperplasia detected through organized screening
Elizabeth Buckley1, Tom Sullivan2, Gelareh Farshid3
1School of Population Health, University of South Australia, GPO Box 2471, Adelaide, South Australia 5001, Australia.
Background:
Few population-based data are available indicating the breast cancer risk following detection of atypia within a breast screening program.
Methods:
Prospectively collected data from the South Australian screening program were linked with the state cancer registry. Absolute and relative breast cancer risk estimates were calculated for ADH and ALH separately, and by age at diagnosis and time since diagnosis. Post-hoc analysis was undertaken of the effect of family history on breast cancer risk.
Results:
Women with ADH and ALH had an increase in relative risk for malignancy (ADH HR 2.81 [95% CI 1.72, 4.59] and (ALH HR 4.14 [95% CI 1.97, 8.69], respectively. Differences in risk profile according to time since diagnosis and age at diagnosis were not statistically significant.
Conclusion:
Estimates of the relative risk of breast cancer are necessary to inform decisions regarding clinical management and/or treatment of women with ADH and ALH.
